Orchestra BioMed Holdings (OBIO) Treasury Shares (2022 - 2026)

Orchestra BioMed Holdings (OBIO) has 5 years of Treasury Shares data on file, last reported at $3.7 million in Q1 2026.

• Quarterly Treasury Shares rose 93.08% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.7 million (up 93.08% YoY) and the FY2025 annual result came in at $2.3 million, up 9.84% from the prior year.
• Treasury Shares climbed to $3.7 million in Q1 2026 per OBIO's latest filing, from $2.3 million in the prior quarter.
• Across five years, Treasury Shares topped out at $3.9 million in Q1 2023 and bottomed at $49237.0 in Q2 2023.
• The 5-year median for Treasury Shares is $2.1 million (2024), against an average of $2.1 million.
• Peak annual rise in Treasury Shares reached 4928.3% in 2024, while the deepest fall reached 56.95% in 2024.
• Tracing OBIO's Treasury Shares over 5 years: stood at $158589.0 in 2022, then surged by 972.72% to $1.7 million in 2023, then increased by 23.12% to $2.1 million in 2024, then climbed by 9.84% to $2.3 million in 2025, then surged by 61.68% to $3.7 million in 2026.
• Per Business Quant, the three latest OBIO Treasury Shares figures stand at $3.7 million (Q1 2026), $2.3 million (Q4 2025), and $2.6 million (Q3 2025).

Peer Comparison